Free Trial

MariMed Inc. (OTCMKTS:MRMD) Sees Large Decline in Short Interest

MariMed logo with Medical background

Key Points

  • MariMed Inc. experienced a significant decrease in short interest, dropping by 66.1% to 16,100 shares by August 31st.
  • Zacks Research upgraded MariMed's rating from "hold" to "strong-buy" on August 13th, contributing to a consensus rating of "Strong Buy" among analysts.
  • The stock is currently priced at $0.14 and has a market capitalization of $56.03 million, with a 12-month price range between $0.07 and $0.23.
  • Five stocks to consider instead of MariMed.

MariMed Inc. (OTCMKTS:MRMD - Get Free Report) was the target of a significant drop in short interest in the month of August. As of August 31st, there was short interest totaling 16,100 shares, a drop of 66.1% from the August 15th total of 47,500 shares. Currently, 0.0% of the company's stock are sold short. Based on an average daily trading volume, of 4,684,900 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily trading volume, of 4,684,900 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.0% of the company's stock are sold short.

Analyst Ratings Changes

Separately, Zacks Research raised shares of MariMed from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, August 13th. Two investment analysts have rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, MariMed has a consensus rating of "Strong Buy".

Get Our Latest Analysis on MariMed

MariMed Stock Down 1.0%

Shares of OTCMKTS:MRMD opened at $0.14 on Friday. The company has a current ratio of 1.12, a quick ratio of 0.36 and a debt-to-equity ratio of 1.25. The stock has a fifty day simple moving average of $0.12 and a two-hundred day simple moving average of $0.10. MariMed has a 12-month low of $0.07 and a 12-month high of $0.23. The stock has a market capitalization of $56.03 million, a price-to-earnings ratio of -4.78 and a beta of 3.01.

About MariMed

(Get Free Report)

MariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in MariMed Right Now?

Before you consider MariMed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MariMed wasn't on the list.

While MariMed currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.